Specialty code 183500000X · Mather, CA
NPI
1588175863
Since 2017
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
10535 Hospital Way
Mather, CA, 95655
Phone (916) 843-7286
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$521K
2,750 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Thanh-Binh Le prescribed most often to Medicare patients was Atorvastatin Calcium, with 293 prescriptions and refills. In total Thanh-Binh Le wrote 2,750 Medicare prescriptions that cost $521K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-22.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 293 | 976 | 129 | $3,587 |
| Metformin Hcl Er Metformin Hcl | 234 | 766 | 116 | $2,383 |
| Jardiance Empagliflozin | 218 | 701 | 102 | $142K |
| Ozempic Semaglutide | 170 | 179 | 38 | $127K |
| Insulin Glargine-Yfgn Generic | 154 | 428 | 74 | $22K |
| Metformin Hcl Generic | 141 | 466 | 64 | $1,869 |
| Glipizide Er Glipizide | 114 | 380 | 50 | $3,964 |
| Glipizide Generic | 112 | 373 | 55 | $1,572 |
| Lisinopril Generic | 105 | 350 | 41 | $1,375 |
| Humulin N Insulin Nph Human Isophane | 100 | 302 | 50 | $18K |
| Losartan Potassium Generic | 78 | 259 | 35 | $969 |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 72 | 216 | 37 | $2,089 |
| Victoza 3-Pak Liraglutide | 69 | 79 | 19 | $60K |
| Amlodipine Besylate Generic | 65 | 212 | 31 | $889 |
| Hydrochlorothiazide Generic | 62 | 200 | 27 | $753 |
Brand drugs: 983 claims; generic drugs: 1,543 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Thanh-Binh Le were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.